Pharmanutra S.p.A. (BIT:PHN)

Market Cap	472.96M
Revenue (ttm)	116.15M
Net Income (ttm)	16.61M
Shares Out	9.60M
EPS (ttm)	1.73
PE Ratio	28.49
Forward PE	22.22
Dividend	1.00 (2.03%)
Ex-Dividend Date	May 5, 2025

Volume	2,614
Average Volume	15,807
Open	49.10
Previous Close	49.25
Day's Range	48.75 - 49.55
52-Week Range	44.85 - 61.20
Beta	0.28
RSI	37.58
Earnings Date	Mar 14, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company’s products primarily include SiderAL, SiderAL Forte, SiderAL...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.